Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Comparing the effectiveness of two treatments for myopia

Official title: A Prospective Study on Clinical Effectiveness After SMILE Versus SMILE Xtra in Myopia

Run by Shanghai Zhongshan Hospital · NCT06973278 · Data updated 2026-11-12

This study is testing which of two eye surgeries, SMILE or SMILE Xtra, works better for people aged 18 to 50 with high myopia to improve their vision and keep it stable over time.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment200 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedFebruary 1, 2023
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedMay 15, 2025
Trial IDNCT06973278 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18 to 50 with high myopia and stable refractive status.

Probably not a fit

Patients with other significant eye diseases or systemic conditions that could affect the outcomes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical efficacy and refractive stability of two surgical techniques, SMILE and SMILE Xtra, in patients suffering from myopia. Participants aged 18 to 50 with high myopia will be recruited, and their visual outcomes will be monitored post-surgery. The study aims to determine which technique offers better results in terms of vision correction and stability over time.

Why it matters

Potential benefit: If successful, this study could provide patients with improved options for treating myopia, leading to better visual outcomes.

How similar studies have gone: Previous studies have shown promising results with SMILE techniques, suggesting that this comparative approach could yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 50 years.
2. High myopia with a manifest refraction spherical equivalent (MRSE) - 6.00D~-10.00D and refractive changes within ± 0.50D in the past two years;
3. Best corrected distance visual acuity (CDVA) ≥ 20/25.
4. Preoperative refractive status is stable (myopia progression not exceeding 0.50D per year for at least 2 years).
5. Predicted residual stromal thickness (RST) ≥ 250μm after lenticule removal. 6.Soft contact lenses discontinued for at least 1 week, rigid contact lenses for at least 3 weeks, and orthokeratology lenses for at least 3 months.

Exclusion Criteria:

1. The presence of other eye diseases: keratoconus or suspected keratoconus, active keratoconjunctivitis, severe dry eye, glaucoma, retinal diseases such as retinal tears or macular degeneration, etc.,
2. The presence of significant corneal scarring or cataracts affects observation.
3. Systemic diseases such as active systemic inflammation, connective tissue diseases, other conditions that prevent

Where it's running

  • Zhongshan Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.